Brekkenlab
@brekkenlab
official Twitter account for the brekken lab. We investigate pathways involved in tumor progression, we mainly tweet abt science & sometimes hockey.
June 23, 2025, for the first-ever VROC #Symposium! A dynamic day of cross-disciplinary collaboration with expert speakers—open to oncologists, veterinarians, researchers, students & more. CME credit available. For more information or to register:cvent.me/V9L888.
Studying the mechanisms of #EpithelialToMesenchymal transition, researchers investigated the kinase AKT and identified a pathway centered on TBK1 required for EMT and metastatic spread in pancreatic cancer in mice. @UTSWCancerBio @brekkenlab @enarner scim.ag/41KOxea
AXL-TBK1 driven AKT3 activation promotes metastasis | Science Signaling science.org/doi/10.1126/sc… Long saga, but it is out. @enarner and a host of others pushed this through. Special thanks to Jim Lorens and his lab @UiB

welcome to X @HHuanglab check out his recent preprint on apCAFs in bioRxiv biorxiv.org/content/10.110…
Happy to share our work on pan-cancer analysis of apCAF at an unprecedented resolution Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches biorxiv.org/content/10.110…
#UTSW biochemist Zhijian "James" Chen, Ph.D., wins the Albert Lasker Basic Medical Research Award, sometimes called “America’s Nobel,” for his discovery of the cGAS enzyme, which senses invading pathogens and triggers immune response. bit.ly/3MQjHIr @LaskerFDN
🚨 Calling all new postdocs 🚨 @UMassChan just launched a new Early Independence Fellows program! Come start your lab at UMass Chan, truly an amazing place to work with world-class colleagues! ✅ Must be within 2 yrs of terminal degree ✅ $440k/yr of support for 5 years! 😱
UMass Chan Medical School seeks the next generation of scientific leaders! Join our research community as a UMass Chan Early Independence Fellow. Get 3-5 years of support. Apply by Dec 1: academicjobsonline.org/ajo/jobs/28425 @UMassChan @RTI_UMassChan
During the day, I am running for Congress. At night, I wait tables. I know what working class Wisconsinites need and I am tired of us lacking true representation in D.C. That’s why I’m running. Can you retweet this, give me a follow, and help me defeat Derrick Van Orden?
Apparently, this tweet was labeled as "adult content". While perplexing, that's technically correct as these fellowships are for adults.
Download freely our updated database of PhD fellowships. We found 189! For each entry, we provide a brief description, deadline, amount, and eligibility criteria. Find it here: research.jhu.edu/rdt/funding-op… Good luck!
Paper out in final form sciencedirect.com/science/articl… @MustangNatalie did a great job driving it. @jbiolchem is a great home for it. $2300 with the @ASBMB member discount - great value. Submission/review/Publication process was fair and quick. BTW that is a lung met lit up by the BB

Debolina Ganguly, PhD (@debog93), a 2024 Parker Scholar at @DanaFarber, studies how metastatic stem cells promote systemic tolerance to tumor antigens & suppress responses to immunotherapy, advancing understanding of patient response. Hear more about PICI’s support of her work.
Looking forward to appreciating our postdocs! #NPAW2024
We have open faculty positions in the area of Tissue Regeneration, Metabolism, and Cancer. Stellar place to work for sure!!
Relentless discovery toward treatments of tomorrow. Join us. 📌Apply by Oct. 15: cri.utsw.edu/careers #relentlessdiscovery #hiring #HiringNow #Cancer #endcancer #Biology #biologybreakthrough #research #researchers #metabolism #tissueregeneration #regenerativemedicine…
Read our latest #WomeninSTEM Viewpoint: we hear from ten women scientists who share their experiences becoming independent researchers and the unique challenges they face. hubs.la/Q02L5mjn0
Thrilled and honored to be a named a Parker Scholar! Very excited to be a part of the PICI network. Grateful for the support of my incredible mentor @JudithAgudo1 and the PICI leadership @DanaFarber
PICI is thrilled to award over $1 million in total to our 2024 class of Early Career Researcher recipients. These bold investigators are propelling #immunotherapy w/ pioneering research that could lead to breakthrough discoveries. Meet the 2024 awardees: linkedin.com/feed/update/ur…
Don’t miss the opportunity to learn about postdoctoral training opportunities at @UTSWMedCenter. Join us on October 15 and be part of the P2P Virtual Workshop. See the post below ⬇️ for more information. @UTSWPostdocs @UTSWGradSchool @BrekkenDeirdre @RueylingLin2
Candidates interested in pursuing #postdoc training @UTSWScience can join us for 'Pathway 2 Postdoc (P2P)' in October to learn more about our program.
We have two open positions in my lab! We are looking for a #postdoc and a #technician to contribute to our mission to define deregulated splicing events driving cancer progression and metastasis. Come science with us! Apply right now! @MoffittNews
Combined therapy makes headway for liver cancer: Newsroom - UT Southwestern, Dallas, Texas utsouthwestern.edu/newsroom/artic… very nice write up. However, disappointing that it is never mentioned that bavi is a UTSW home grown drug. @utswcancer @NewsUtsw16519 also PS is not a protein
We’re less than 2 weeks away! Register here: bit.ly/42owfhm Attention breast cancer community: Check out our keynote speakers, Elizabeth Mittendorf, M.D., Ph.D., M.H.C.M., and Joan Massagué, Ph.D. @EMittendorfMD @LabMassague
CABTRAC @cabtrac will be hosting a Town Hall with the NCI Training Branch @NCI_Training on April 18 from 3-4:30 EST You need to register to join. See link cabtrac.org/nci/ Listen, ask questions, interact
